Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth (Q24293042)

19

0 references

Gregory D. Plowman

object named as

Greg Plowman

14

0 references

author name string

Qi Pan

1

0 references

Yvan Chanthery

2

0 references

Wei-Ching Liang

3

0 references

Scott Stawicki

4

0 references

Judy Mak

5

0 references

Nisha Rathore

6

0 references

Raymond K Tong

7

0 references

Joe Kowalski

8

0 references

Sharon Fong Yee

9

0 references

Glenn Pacheco

10

0 references

Sarajane Ross

11

0 references

Zhiyong Cheng

12

0 references

Jennifer Le Couter

13

0 references

Franklin Peale

15

0 references

Alexander W Koch

16

0 references

Yan Wu

17

0 references

Anil Bagri

18

0 references

Ryan J Watts

Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma

20

0 references

language of work or name

English

0 references

publication date

January 2007

0 references

published in

Cancer Cell

0 references

volume

11

0 references

issue

1

0 references

page(s)

53-67

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

The role of neuropilin in vascular and tumor biology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Cellular abnormalities of blood vessels as targets in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilins in neoplasms: expression, regulation, and function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Akt signaling mediates VEGF/VPF vascular permeability in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin Is a Semaphorin III Receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

VEGF-receptor signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Common mechanisms of nerve and blood vessel wiring

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Angiogenesis as a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

GIPC, a PDZ domain containing protein, interacts specifically with the C terminus of RGS-GAIP

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin-1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor-dependent Endothelial Cell Migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

C terminus of RGS-GAIP-interacting protein conveys neuropilin-1-mediated signaling during angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021

Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.10.018

7 January 2021